Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Effect of Early-Life Fluoxetine on Anxiety-Like Behaviors in BDNF Val66Met Mice.

Dincheva I, Yang J, Li A, Marinic T, Freilingsdorf H, Huang C, Casey BJ, Hempstead B, Glatt CE, Lee FS, Bath KG, Jing D.

Am J Psychiatry. 2017 Dec 1;174(12):1203-1213. doi: 10.1176/appi.ajp.2017.15121592. Epub 2017 Oct 31.

2.

Postnatal Evaluation of Cervical Ribs in Control Rats.

Mukerji P, Glatt C, Gannon S, Lewis JM.

Birth Defects Res. 2017 Oct 2;109(16):1301-1304. doi: 10.1002/bdr2.1090. Epub 2017 Jul 29.

PMID:
28755433
3.

Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder.

Song M, Mathews CA, Stewart SE, Shmelkov SV, Mezey JG, Rodriguez-Flores JL, Rasmussen SA, Britton JC, Oh YS, Walkup JT, Lee FS, Glatt CE.

PLoS One. 2017 Jan 13;12(1):e0169994. doi: 10.1371/journal.pone.0169994. eCollection 2017.

4.

Heritability of major depressive and comorbid anxiety disorders in multi-generational families at high risk for depression.

Guffanti G, Gameroff MJ, Warner V, Talati A, Glatt CE, Wickramaratne P, Weissman MM.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1072-1079. doi: 10.1002/ajmg.b.32477. Epub 2016 Jul 25.

PMID:
27452917
5.

Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species.

Gee DG, Fetcho RN, Jing D, Li A, Glatt CE, Drysdale AT, Cohen AO, Dellarco DV, Yang RR, Dale AM, Jernigan TL, Lee FS, Casey BJ; PING Consortium.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4500-5. doi: 10.1073/pnas.1600013113. Epub 2016 Mar 21.

6.

Novel variants in ZNF34 and other brain-expressed transcription factors are shared among early-onset MDD relatives.

Subaran RL, Odgerel Z, Swaminathan R, Glatt CE, Weissman MM.

Am J Med Genet B Neuropsychiatr Genet. 2016 Apr;171B(3):333-41. doi: 10.1002/ajmg.b.32408. Epub 2016 Jan 29.

7.

Treating the Developing versus Developed Brain: Translating Preclinical Mouse and Human Studies.

Casey BJ, Glatt CE, Lee FS.

Neuron. 2015 Jun 17;86(6):1358-68. doi: 10.1016/j.neuron.2015.05.020. Review.

8.

FAAH genetic variation enhances fronto-amygdala function in mouse and human.

Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC, Ra S, Gray JM, Yang R, DeGruccio AM, Huang C, Cravatt BF, Glatt CE, Hill MN, Casey BJ, Lee FS.

Nat Commun. 2015 Mar 3;6:6395. doi: 10.1038/ncomms7395.

9.

Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation.

Glatt CE, Lee FS.

Biol Psychiatry. 2016 Jan 1;79(1):25-31. doi: 10.1016/j.biopsych.2014.12.020. Epub 2015 Jan 8. Review.

10.

Nonlinear developmental trajectory of fear learning and memory.

King EC, Pattwell SS, Sun A, Glatt CE, Lee FS.

Ann N Y Acad Sci. 2013 Nov;1304:62-9. doi: 10.1111/nyas.12280. Epub 2013 Oct 31. Review.

11.

Childhood separation anxiety and the pathogenesis and treatment of adult anxiety.

Milrod B, Markowitz JC, Gerber AJ, Cyranowski J, Altemus M, Shapiro T, Hofer M, Glatt C.

Am J Psychiatry. 2014 Jan;171(1):34-43. doi: 10.1176/appi.ajp.2013.13060781. Review.

PMID:
24129927
12.

Anxiety-associated alternative polyadenylation of the serotonin transporter mRNA confers translational regulation by hnRNPK.

Yoon Y, McKenna MC, Rollins DA, Song M, Nuriel T, Gross SS, Xu G, Glatt CE.

Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11624-9. doi: 10.1073/pnas.1301485110. Epub 2013 Jun 24.

13.

Sensitive periods in fear learning and memory.

King EC, Pattwell SS, Glatt CE, Lee FS.

Stress. 2014 Jan;17(1):13-21. doi: 10.3109/10253890.2013.796355. Epub 2013 May 28. Review.

14.

Caloric restriction enhances fear extinction learning in mice.

Riddle MC, McKenna MC, Yoon YJ, Pattwell SS, Santos PM, Casey BJ, Glatt CE.

Neuropsychopharmacology. 2013 May;38(6):930-7. doi: 10.1038/npp.2012.268. Epub 2013 Jan 3.

15.

Treating the developing brain: implications from human imaging and mouse genetics.

Casey BJ, Pattwell SS, Glatt CE, Lee FS.

Annu Rev Med. 2013;64:427-39. doi: 10.1146/annurev-med-052611-130408. Epub 2012 Nov 26. Review.

16.

Biology trumps statistics in the postgenomic era.

Glatt CE.

Behav Brain Sci. 2012 Oct;35(5):366-7. doi: 10.1017/S0140525X12001008.

PMID:
23095387
17.

The brain-derived neurotrophic factor Val66Met polymorphism moderates early deprivation effects on attention problems.

Gunnar MR, Wenner JA, Thomas KM, Glatt CE, McKenna MC, Clark AG.

Dev Psychopathol. 2012 Nov;24(4):1215-23. doi: 10.1017/S095457941200065X.

18.

Altered fear learning across development in both mouse and human.

Pattwell SS, Duhoux S, Hartley CA, Johnson DC, Jing D, Elliott MD, Ruberry EJ, Powers A, Mehta N, Yang RR, Soliman F, Glatt CE, Casey BJ, Ninan I, Lee FS.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16318-23. doi: 10.1073/pnas.1206834109. Epub 2012 Sep 17.

19.

Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory.

Hartley CA, McKenna MC, Salman R, Holmes A, Casey BJ, Phelps EA, Glatt CE.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5493-8. doi: 10.1073/pnas.1202044109. Epub 2012 Mar 19.

20.

Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics.

Dincheva I, Glatt CE, Lee FS.

Neuroscientist. 2012 Oct;18(5):439-51. Epub 2012 Feb 24. Review.

21.

Exploring implementation of the 2010 Institute of Medicine's Child and Adult Food Care Program recommendations for after-school snacks.

Nanney MS, Glatt C.

Public Health Nutr. 2013 Jun;16(6):1140-6. doi: 10.1017/S1368980011002722. Epub 2011 Nov 4.

22.

Transitional and translational studies of risk for anxiety.

Casey BJ, Ruberry EJ, Libby V, Glatt CE, Hare T, Soliman F, Duhoux S, Frielingsdorf H, Tottenham N.

Depress Anxiety. 2011 Jan;28(1):18-28. doi: 10.1002/da.20783. Review.

23.

Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.

Kanellopoulos D, Gunning FM, Morimoto SS, Hoptman MJ, Murphy CF, Kelly RE, Glatt C, Lim KO, Alexopoulos GS.

Am J Geriatr Psychiatry. 2011 Jan;19(1):13-22.

24.

Imaging genetics and development: challenges and promises.

Casey BJ, Soliman F, Bath KG, Glatt CE.

Hum Brain Mapp. 2010 Jun;31(6):838-51. doi: 10.1002/hbm.21047. Review.

25.

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Alexopoulos GS, Glatt CE, Hoptman MJ, Kanellopoulos D, Murphy CF, Kelly RE Jr, Morimoto SS, Lim KO, Gunning FM.

J Affect Disord. 2010 Sep;125(1-3):262-8. doi: 10.1016/j.jad.2010.02.115. Epub 2010 Mar 25.

26.

High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

Lin Z, Zhao Y, Chung CY, Zhou Y, Xiong N, Glatt CE, Isacson O.

FASEB J. 2010 Jul;24(7):2191-200. doi: 10.1096/fj.09-140368. Epub 2010 Feb 24.

27.

A genetic variant BDNF polymorphism alters extinction learning in both mouse and human.

Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, Jing D, Tottenham N, Amso D, Somerville LH, Voss HU, Glover G, Ballon DJ, Liston C, Teslovich T, Van Kempen T, Lee FS, Casey BJ.

Science. 2010 Feb 12;327(5967):863-6. doi: 10.1126/science.1181886. Epub 2010 Jan 14.

28.

Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Gyawali S, Subaran R, Weissman MM, Hershkowitz D, McKenna MC, Talati A, Fyer AJ, Wickramaratne P, Adams PB, Hodge SE, Schmidt CJ, Bannon MJ, Glatt CE.

Biol Psychiatry. 2010 Feb 15;67(4):331-8. doi: 10.1016/j.biopsych.2009.10.015. Epub 2009 Dec 6.

29.

Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression.

Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Glatt CE, Latoussakis V, Kelly RE Jr, Kanellopoulos D, Klimstra S, Lim KO, Young RC, Hoptman MJ.

J Affect Disord. 2009 Dec;119(1-3):132-41. doi: 10.1016/j.jad.2009.03.004. Epub 2009 Apr 17.

30.

Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development.

Casey BJ, Glatt CE, Tottenham N, Soliman F, Bath K, Amso D, Altemus M, Pattwell S, Jones R, Levita L, McEwen B, MagariƱos AM, Gunnar M, Thomas KM, Mezey J, Clark AG, Hempstead BL, Lee FS.

Neuroscience. 2009 Nov 24;164(1):108-20. doi: 10.1016/j.neuroscience.2009.03.081. Epub 2009 Apr 7. Review.

31.

Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease.

Wahner AD, Glatt CE, Bronstein JM, Ritz B.

Neurosci Lett. 2007 Feb 21;413(3):274-8. Epub 2006 Dec 27.

32.

Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease.

Glatt C, Almonte M, Taylor T, Edwards RH, Freimer N, Tanner C; Parkinson Study Group.

Mov Disord. 2006 Mar;21(3):426-7. No abstract available.

PMID:
16450345
33.

Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.

Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B.

Hum Mol Genet. 2006 Jan 15;15(2):299-305. Epub 2005 Dec 8.

34.

Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16.

Glatt CE, Carlson E, Taylor TR, Risch N, Reus VI, Schaefer CA.

Neuron. 2005 Dec 8;48(5):704-5; author reply 705-6. No abstract available.

35.

Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points.

Glatt CM, Ouyang M, Welsh W, Green JW, Connor JO, Frame SR, Everds NE, Poindexter G, Snajdr S, Delker DA.

Environ Health Perspect. 2005 Oct;113(10):1354-61.

36.

The effect of rare human sequence variants on the function of vesicular monoamine transporter 2.

Burman J, Tran CH, Glatt C, Freimer NB, Edwards RH.

Pharmacogenetics. 2004 Sep;14(9):587-94.

PMID:
15475732
37.

Identification of genetic variants in the neuronal form of tryptophan hydroxylase (TPH2).

Breidenthal SE, White DJ, Glatt CE.

Psychiatr Genet. 2004 Jun;14(2):69-72.

PMID:
15167691
38.

A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins.

Thomas K, Aalbers M, Bannon GA, Bartels M, Dearman RJ, Esdaile DJ, Fu TJ, Glatt CM, Hadfield N, Hatzos C, Hefle SL, Heylings JR, Goodman RE, Henry B, Herouet C, Holsapple M, Ladics GS, Landry TD, MacIntosh SC, Rice EA, Privalle LS, Steiner HY, Teshima R, Van Ree R, Woolhiser M, Zawodny J.

Regul Toxicol Pharmacol. 2004 Apr;39(2):87-98.

PMID:
15041142
39.

Re-screening serotonin receptors for genetic variants identifies population and molecular genetic complexity.

Glatt CE, Tampilic M, Christie C, DeYoung J, Freimer NB.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):92-100.

PMID:
14681923
40.

Pharmacogenetics of monoamine transporters.

Glatt CE, Reus VI.

Pharmacogenomics. 2003 Sep;4(5):583-96. Review.

PMID:
12943466
41.

Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign.

Glatt CE, Freimer NB.

Trends Genet. 2002 Jun;18(6):307-12. Review.

PMID:
12044360
42.

Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population.

McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki SL, Mathews CA, Neylan T, Glatt CE, Escamilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E, Meyer JM, Leon P, Sandkuijl LA, Freimer NB, Chen H.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11485-90.

43.

Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes.

Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, Risch N, Freimer NB.

Nat Genet. 2001 Apr;27(4):435-8.

PMID:
11279528
44.
45.

Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluR1) and the inositol 1,4,5-trisphosphate receptor in rat brain.

Fotuhi M, Sharp AH, Glatt CE, Hwang PM, von Krosigk M, Snyder SH, Dawson TM.

J Neurosci. 1993 May;13(5):2001-12.

46.

Cloning and expression of an adenylyl cyclase localized to the corpus striatum.

Glatt CE, Snyder SH.

Nature. 1993 Feb 11;361(6412):536-8.

PMID:
8429907
47.

Carbon monoxide: a putative neural messenger.

Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH.

Science. 1993 Jan 15;259(5093):381-4. Erratum in: Science 1994 Jan 7;263(5143):15.

PMID:
7678352
48.

High brain densities of the immunophilin FKBP colocalized with calcineurin.

Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH.

Nature. 1992 Aug 13;358(6387):584-7.

PMID:
1380130
49.

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH.

Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6711-5.

50.

A novel K+ channel with unique localizations in mammalian brain: molecular cloning and characterization.

Hwang PM, Glatt CE, Bredt DS, Yellen G, Snyder SH.

Neuron. 1992 Mar;8(3):473-81.

PMID:
1550672

Supplemental Content

Support Center